Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Technology Reporter.
Press releases published on August 28, 2025

CryptoVirally Expands Web3 Marketing Services, Unifying PR, KOLs, and Community Growth Into One Full-Funnel Program
Bucharest, Romania, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CryptoVirally today announced an expanded suite of crypto marketing and Web3 marketing solutions that combine press releases, media placements, influencer and KOL activations, community growth, and …

Candel Therapeutics to Participate in Upcoming Investor Conferences in September
NEEDHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, …

IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company has regained compliance with the minimum bid price …

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
CORAL GABLES, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …

EXL to participate in Citi Global TMT Conference in New York
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc., (NASDAQ: EXLS) announced today that Vivek Jetley, president and head of Insurance, Healthcare and Life Sciences and Maurizio Nicolelli, chief financial officer, will present at the Citi …

Biptap Expands to Africa with Central African Republic Deal
Dubai, UAE , Aug. 28, 2025 (GLOBE NEWSWIRE) -- Biptap expands to Africa with a landmark partnership in the Central African Republic, marking a major step toward redefining financial access across the continent. The deal, signed between Biptap CEO Jonathan …

Tidewave Bio Completes FDA INTERACT Meeting for TBC-1, a Universal Cell Therapy Platform in Solid Tumors
LOS ANGELES, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tidewave Bio, a biotechnology company developing a universal, off-the-shelf, gene-enhanced antigen-presenting cell therapy platform, today announced the successful completion of its FDA INTERACT meeting. This …

CytomX Therapeutics to Present at Upcoming September Investor Conferences
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will participate in the following investor …

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to …

Collegium to Participate in Upcoming Investor Conferences
STOUGHTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025 …

Easily Integrate Position, Navigation and Timing Technology With Microchip’s Portfolio of GNSS Disciplined Oscillator Modules
CHANDLER, Ariz., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aerospace and defense applications rely on Position, Navigation and Timing (PNT) technology for mission-critical accuracy and reliability. However, integrating PNT into a design requires extensive domain …

Kyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event
KYV-101 has the potential to deliver durable, drug-free, disease-free remission in myasthenia gravis and set a new treatment standard for stiff person syndrome Innovative FDA-aligned KYSA-6 Phase 3 trial design for myasthenia gravis supports clear and …

Fusemachines to Present at the 2025 Annual Gateway Conference on September 3rd
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Fusemachines, Inc. (“Fusemachines” or the “Company”), a leading provider of enterprise AI products and services, today announced its upcoming attendance of the 2025 Annual Gateway Conference, an institutional …

TG Therapeutics to Participate in the Cantor Global Healthcare Conference
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Cantor Global Healthcare Conference, being held in New York, …

RentRedi Delivers Fast, Flexible Financing, powered by Stripe Capital
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- RentRedi, the fastest-growing property management software for smart real estate investors, today announced the launch of a new financing solution powered by Stripe Capital that provides fast, flexible funding to …

NETCLASS TECHNOLOGY INC Announces Headquarters Relocation to Singapore and Planned Acquisition of Vietnam-based LBC International Company Limited
SHANGHAI and HONG KONG, Aug. 28, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, today announced …

Entera Bio to Unveil Clinical and Non-Clinical Data Across 3 Oral Peptide Programs at Upcoming September Conferences
Osteoporosis Program: Phase 2 analysis exploring the dual actions of oral PTH(1-34) tablet treatment, EB613 on trabecular and cortical bone, and Next-Gen EB613 PK/PD data slated for oral and poster presentations at ASBMR Short Bowel Syndome and Rare GI …

Psyence BioMed to Present at the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced …

Dog-Walker.io Announces DOGWALK Token Pre-Sale and Global Community Giveaway with a $500,000 Prize Pool
LONDON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Dog-Walker.io today announced the launch of the pre-sale for its native DogWalkerToken (DWT). The project, which combines blockchain technology with the pet care industry, has already attracted early interest from …

Crescent Biopharma to Present at September Investor Conferences
WALTHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management …